Confirm BioSciences out of San Diego, Calif. has been acquired by Lenexa-based Clinical Reference Laboratory (CRL).
CRL is one of the largest privately held clinical testing laboratories in the U.S., and now leverages Confirm’s massive customer base in Drugs of Abuse testing, large consumer-based retail contracts and current pipeline of COVID-19 testing products.
Confirm BioSciences is a a leading provider of comprehensive screening tools and solutions founded in 2008. The company’s expansive product lines are sold by several retail giants nationwide.
Founded more than 30 years ago, CRL performs hundreds of thousands of tests weekly for clients of all sizes from its dedicated facilities located in Kansas.
More than 700 CRL associates process and report results for some of the world’s largest companies including life insurance, transportation, pharmaceutical, healthcare and financial service organizations. CRL performs high complexity molecular diagnostic tests including COVID-19 testing, toxicology and general lab testing, working with a diverse array of partners.
“Working closely with the Confirm BioSciences team as a strategic partner gave us insight into what an impressive organization it is, so an acquisition was a natural next step to build out our growth strategy,” said CRL President & CEO Robert Thompson. “As a privately held, family-owned company, CRL has a lot in common with Confirm. We share the same values and have a similar culture, so it’s an excellent fit.”
“We’re so excited about joining the CRL family,” said Albert Berger, CEO, Confirm BioSciences. “While partnering with CRL on recent projects, we developed a great relationship, and becoming part of the CRL organization will allow the Confirm BioSciences team to focus on the services we provide to our customers while expanding our capabilities. It will be business as usual, but with even more firepower.”